Skip to main content
Top
Published in: BMC Cancer 1/2013

Open Access 01-12-2013 | Research article

Diagnostic accuracy of diffuse reflectance imaging for early detection of pre-malignant and malignant changes in the oral cavity: a feasibility study

Authors: Manju M Stephen, Jayaraj L Jayanthi, Nisha G Unni, Philip E Kolady, Valappil T Beena, Panniyammakal Jeemon, Narayanan Subhash

Published in: BMC Cancer | Issue 1/2013

Login to get access

Abstract

Background

Diffusely reflected light is influenced by cytologic and morphologic changes that take place during tissue transformation, such as, nuclear changes, extracellular matrix structure and composition as well as blood flow. Albeit with varying degree of sensitivity and specificity, the properties of diffusely reflected light in discriminating a variety of oral lesions have been demonstrated by our group in multiple studies using point monitoring systems. However, the point monitoring system could not identify the region with the most malignant potential in a single sitting.

Methods

In order to scan the entire lesion, we developed a multi-spectral imaging camera system that records diffuse reflectance (DR) images of the oral lesion at 545 and 575 nm with white light illumination. The diagnostic accuracy of the system for 2-dimensional DR imaging of pre-malignant and malignant changes in the oral cavity was evaluated through a clinical study in 55 patients and 23 healthy volunteers. The DR imaging data were compared with gold standard tissue biopsy and histopathology results.

Results

In total 106- normal/clinically healthy sites, 20- pre-malignant and 29- malignant (SCC) sites were compared. While the median pixel value of the R545/R575 image ratio for normal/clinically healthy tissue was 0.87 (IQR = 0.82-0.94), they were 1.35 (IQR = 1.13-1.67) and 2.44 (IQR = 1.78-3.80) for pre-malignant and malignant lesions, respectively. Area under the ROC curve to differentiate malignant from normal/clinically healthy [AUC = 0.99 (95% CI: 0.99-1.00)], pre-malignant from normal/clinically healthy [AUC = 0.94 (95% CI: 0.86-1.00)], malignant from pre-malignant [AUC = 0.84 (95% CI: 0.73-0.95)] and pre-malignant and malignant from normal/clinically healthy [AUC = 0.97 (95% CI: 0.94-1.00)] lesions were desirable.

Conclusion

We find DR imaging to be very effective as a screening tool in locating the potentially malignant areas of oral lesions with relatively good diagnostic accuracy while comparing it to the gold standard histopathology.
Appendix
Available only for authorised users
Literature
1.
go back to reference Mignogna MD, Fedele S, Lo Russo L: The World Cancer Report and the burden of oral cancer. Eur J Cancer Prev. 2004, 13 (2): 139-142.CrossRefPubMed Mignogna MD, Fedele S, Lo Russo L: The World Cancer Report and the burden of oral cancer. Eur J Cancer Prev. 2004, 13 (2): 139-142.CrossRefPubMed
3.
go back to reference Carpenter WM, Silverman S: Oral cancer: the role of the dentist in prevention and early detection. Dent Today. 2001, 20 (5): 92-97.PubMed Carpenter WM, Silverman S: Oral cancer: the role of the dentist in prevention and early detection. Dent Today. 2001, 20 (5): 92-97.PubMed
4.
go back to reference Sankaranarayanan R, Ramadas K, Thomas G, Muwonge R, Thara S, Mathew B, Rajan B: Effect of screening on oral cancer mortality in Kerala, India: a cluster-randomised controlled trial. Lancet. 2005, 365 (9475): 1927-1933. 10.1016/S0140-6736(05)66658-5.CrossRefPubMed Sankaranarayanan R, Ramadas K, Thomas G, Muwonge R, Thara S, Mathew B, Rajan B: Effect of screening on oral cancer mortality in Kerala, India: a cluster-randomised controlled trial. Lancet. 2005, 365 (9475): 1927-1933. 10.1016/S0140-6736(05)66658-5.CrossRefPubMed
5.
go back to reference Zhang L, Williams M, Poh CF, Laronde D, Epstein JB, Durham S, Nakamura H, Berean K, Hovan A, Le ND: Toluidine blue staining identifies high-risk primary oral premalignant lesions with poor outcome. Cancer Res. 2005, 65 (17): 8017-8021.PubMed Zhang L, Williams M, Poh CF, Laronde D, Epstein JB, Durham S, Nakamura H, Berean K, Hovan A, Le ND: Toluidine blue staining identifies high-risk primary oral premalignant lesions with poor outcome. Cancer Res. 2005, 65 (17): 8017-8021.PubMed
6.
go back to reference Lane PM, Gilhuly T, Whitehead P, Zeng H, Poh CF, Ng S, Williams PM, Zhang L, Rosin MP, MacAulay CE: Simple device for the direct visualization of oral-cavity tissue fluorescence. J Biomed Opt. 2006, 11 (2): 024006-10.1117/1.2193157.CrossRefPubMed Lane PM, Gilhuly T, Whitehead P, Zeng H, Poh CF, Ng S, Williams PM, Zhang L, Rosin MP, MacAulay CE: Simple device for the direct visualization of oral-cavity tissue fluorescence. J Biomed Opt. 2006, 11 (2): 024006-10.1117/1.2193157.CrossRefPubMed
7.
go back to reference Poh CF, Ng SP, Williams PM, Zhang L, Laronde DM, Lane P, Macaulay C, Rosin MP: Direct fluorescence visualization of clinically occult high-risk oral premalignant disease using a simple hand-held device. Head Neck. 2007, 29 (1): 71-76. 10.1002/hed.20468.CrossRefPubMed Poh CF, Ng SP, Williams PM, Zhang L, Laronde DM, Lane P, Macaulay C, Rosin MP: Direct fluorescence visualization of clinically occult high-risk oral premalignant disease using a simple hand-held device. Head Neck. 2007, 29 (1): 71-76. 10.1002/hed.20468.CrossRefPubMed
8.
go back to reference Utzinger U, Brewer M, Silva E, Gershenson D, Blast RC, Follen M, Richards-Kortum R: Reflectance spectroscopy for in vivo characterization of ovarian tissue. Lasers Surg Med. 2001, 28 (1): 56-66. 10.1002/1096-9101(2001)28:1<56::AID-LSM1017>3.0.CO;2-L.CrossRefPubMed Utzinger U, Brewer M, Silva E, Gershenson D, Blast RC, Follen M, Richards-Kortum R: Reflectance spectroscopy for in vivo characterization of ovarian tissue. Lasers Surg Med. 2001, 28 (1): 56-66. 10.1002/1096-9101(2001)28:1<56::AID-LSM1017>3.0.CO;2-L.CrossRefPubMed
9.
go back to reference de Veld DC, Skurichina M, Witjes MJ, Duin RP, Sterenborg HJ, Roodenburg JL: Autofluorescence and diffuse reflectance spectroscopy for oral oncology. Lasers Surg Med. 2005, 36 (5): 356-364. 10.1002/lsm.20122.CrossRefPubMed de Veld DC, Skurichina M, Witjes MJ, Duin RP, Sterenborg HJ, Roodenburg JL: Autofluorescence and diffuse reflectance spectroscopy for oral oncology. Lasers Surg Med. 2005, 36 (5): 356-364. 10.1002/lsm.20122.CrossRefPubMed
10.
go back to reference Subhash N, Mallia JR, Thomas SS, Mathews A, Sebastian P, Madhavan J: Oral cancer detection using diffuse reflectance spectral ratio R540/R575 of oxygenated hemoglobin bands. J Biomed Opt. 2006, 11 (1): 014018-10.1117/1.2165184.CrossRefPubMed Subhash N, Mallia JR, Thomas SS, Mathews A, Sebastian P, Madhavan J: Oral cancer detection using diffuse reflectance spectral ratio R540/R575 of oxygenated hemoglobin bands. J Biomed Opt. 2006, 11 (1): 014018-10.1117/1.2165184.CrossRefPubMed
11.
go back to reference Jayanthi JL, Nisha GU, Manju S, Philip EK, Jeemon P, Baiju KV, Beena VT, Subhash N: Diffuse reflectance spectroscopy: diagnostic accuracy of a non-invasive screening technique for early detection of malignant changes in the oral cavity. BMJ Open. 2011, 1 (1): e000071-10.1136/bmjopen-2011-000071.CrossRefPubMedPubMedCentral Jayanthi JL, Nisha GU, Manju S, Philip EK, Jeemon P, Baiju KV, Beena VT, Subhash N: Diffuse reflectance spectroscopy: diagnostic accuracy of a non-invasive screening technique for early detection of malignant changes in the oral cavity. BMJ Open. 2011, 1 (1): e000071-10.1136/bmjopen-2011-000071.CrossRefPubMedPubMedCentral
12.
go back to reference Jayanthi JL, Subhash N, Stephen M, Philip EK, Beena VT: Comparative evaluation of the diagnostic performance of autofluorescence and diffuse reflectance in oral cancer detection: a clinical study. J Biophotonics. 2011, 4 (10): 696-706. 10.1002/jbio.201100037.CrossRefPubMed Jayanthi JL, Subhash N, Stephen M, Philip EK, Beena VT: Comparative evaluation of the diagnostic performance of autofluorescence and diffuse reflectance in oral cancer detection: a clinical study. J Biophotonics. 2011, 4 (10): 696-706. 10.1002/jbio.201100037.CrossRefPubMed
13.
go back to reference Mallia RJ, Narayanan S, Madhavan J, Sebastian P, Kumar R, Mathews A, Thomas G, Radhakrishnan J: Diffuse reflection spectroscopy: an alternative to autofluorescence spectroscopy in tongue cancer detection. Appl Spectrosc. 2010, 64 (4): 409-418. 10.1366/000370210791114347.CrossRefPubMed Mallia RJ, Narayanan S, Madhavan J, Sebastian P, Kumar R, Mathews A, Thomas G, Radhakrishnan J: Diffuse reflection spectroscopy: an alternative to autofluorescence spectroscopy in tongue cancer detection. Appl Spectrosc. 2010, 64 (4): 409-418. 10.1366/000370210791114347.CrossRefPubMed
14.
go back to reference Mallia RJ, Subhash N, Mathews A, Kumar R, Thomas SS, Sebastian P, Madhavan J: Clinical grading of oral mucosa by curve-fitting of corrected autofluorescence using diffuse reflectance spectra. Head Neck. 2009, 32 (6): 763-779. Mallia RJ, Subhash N, Mathews A, Kumar R, Thomas SS, Sebastian P, Madhavan J: Clinical grading of oral mucosa by curve-fitting of corrected autofluorescence using diffuse reflectance spectra. Head Neck. 2009, 32 (6): 763-779.
15.
go back to reference De Veld DC, Witjes MJ, Sterenborg HJ, Roodenburg JL: The status of in vivo autofluorescence spectroscopy and imaging for oral oncology. Oral Oncol. 2005, 41 (2): 117-131. 10.1016/j.oraloncology.2004.07.007.CrossRefPubMed De Veld DC, Witjes MJ, Sterenborg HJ, Roodenburg JL: The status of in vivo autofluorescence spectroscopy and imaging for oral oncology. Oral Oncol. 2005, 41 (2): 117-131. 10.1016/j.oraloncology.2004.07.007.CrossRefPubMed
16.
go back to reference Roblyer D, Kurachi C, Stepanek V, Williams MD, El-Naggar AK, Lee JJ, Gillenwater AM, Richards-Kortum R: Objective detection and delineation of oral neoplasia using autofluorescence imaging. Cancer Prev Res (Phila). 2009, 2 (5): 423-431. 10.1158/1940-6207.CAPR-08-0229.CrossRef Roblyer D, Kurachi C, Stepanek V, Williams MD, El-Naggar AK, Lee JJ, Gillenwater AM, Richards-Kortum R: Objective detection and delineation of oral neoplasia using autofluorescence imaging. Cancer Prev Res (Phila). 2009, 2 (5): 423-431. 10.1158/1940-6207.CAPR-08-0229.CrossRef
17.
go back to reference Rahman MS, Ingole N, Roblyer D, Stepanek V, Richards-Kortum R, Gillenwater A, Shastri S, Chaturvedi P: Evaluation of a low-cost, portable imaging system for early detection of oral cancer. Head Neck Oncol. 2010, 2: 10-10.1186/1758-3284-2-10.CrossRefPubMedPubMedCentral Rahman MS, Ingole N, Roblyer D, Stepanek V, Richards-Kortum R, Gillenwater A, Shastri S, Chaturvedi P: Evaluation of a low-cost, portable imaging system for early detection of oral cancer. Head Neck Oncol. 2010, 2: 10-10.1186/1758-3284-2-10.CrossRefPubMedPubMedCentral
18.
go back to reference Subhash N, Jayanthi JL: A Novel Multi-Spectral Diffuse Reflectance Imaging Camera for Diagnosis of Oral Cavity Cancer. 2011, India: Controller General of Patents Designs and Trademarks, Government of India, Patent Number 2870/CHE/2011 Subhash N, Jayanthi JL: A Novel Multi-Spectral Diffuse Reflectance Imaging Camera for Diagnosis of Oral Cavity Cancer. 2011, India: Controller General of Patents Designs and Trademarks, Government of India, Patent Number 2870/CHE/2011
19.
go back to reference Jayanthi JL, Subhash N, Manju S, Nisha GU, Beena VT: Diffuse reflectance imaging: a tool for guided biopsy. Proc of SPIE. 2012, 8220: 1-9. Jayanthi JL, Subhash N, Manju S, Nisha GU, Beena VT: Diffuse reflectance imaging: a tool for guided biopsy. Proc of SPIE. 2012, 8220: 1-9.
20.
go back to reference Volynskaya Z, Haka AS, Bechtel KL, Fitzmaurice M, Shenk R, Wang N, Nazemi J, Dasari RR, Feld MS: Diagnosing breast cancer using diffuse reflectance spectroscopy and intrinsic fluorescence spectroscopy. J Biomed Opt. 2008, 13 (2): 024012-10.1117/1.2909672.CrossRefPubMed Volynskaya Z, Haka AS, Bechtel KL, Fitzmaurice M, Shenk R, Wang N, Nazemi J, Dasari RR, Feld MS: Diagnosing breast cancer using diffuse reflectance spectroscopy and intrinsic fluorescence spectroscopy. J Biomed Opt. 2008, 13 (2): 024012-10.1117/1.2909672.CrossRefPubMed
21.
go back to reference Ferreira DS, Coutinho PG, Castanheira ES, Correia JH, Minas G: Fluorescence and diffuse reflectance spectroscopy for early cancer detection using a new strategy towards the development of a miniaturized system. Conf Proc IEEE Eng Med Biol Soc. 2010, 2010: 1210-1213.PubMed Ferreira DS, Coutinho PG, Castanheira ES, Correia JH, Minas G: Fluorescence and diffuse reflectance spectroscopy for early cancer detection using a new strategy towards the development of a miniaturized system. Conf Proc IEEE Eng Med Biol Soc. 2010, 2010: 1210-1213.PubMed
22.
go back to reference Mirabal YN, Chang SK, Atkinson EN, Malpica A, Follen M, Richards-Kortum R: Reflectance spectroscopy for in vivo detection of cervical precancer. J Biomed Opt. 2002, 7 (4): 587-594. 10.1117/1.1502675.CrossRefPubMed Mirabal YN, Chang SK, Atkinson EN, Malpica A, Follen M, Richards-Kortum R: Reflectance spectroscopy for in vivo detection of cervical precancer. J Biomed Opt. 2002, 7 (4): 587-594. 10.1117/1.1502675.CrossRefPubMed
23.
go back to reference Kemmner W, Wan K, Ruttinger S, Ebert B, Macdonald R, Klamm U, Moesta KT: Silencing of human ferrochelatase causes abundant protoporphyrin-IX accumulation in colon cancer. FASEB J. 2008, 22 (2): 500-509.CrossRefPubMed Kemmner W, Wan K, Ruttinger S, Ebert B, Macdonald R, Klamm U, Moesta KT: Silencing of human ferrochelatase causes abundant protoporphyrin-IX accumulation in colon cancer. FASEB J. 2008, 22 (2): 500-509.CrossRefPubMed
Metadata
Title
Diagnostic accuracy of diffuse reflectance imaging for early detection of pre-malignant and malignant changes in the oral cavity: a feasibility study
Authors
Manju M Stephen
Jayaraj L Jayanthi
Nisha G Unni
Philip E Kolady
Valappil T Beena
Panniyammakal Jeemon
Narayanan Subhash
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2013
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-13-278

Other articles of this Issue 1/2013

BMC Cancer 1/2013 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine